Great piece and great job finding it!! There are some things the board has known for a little while now but what stuck out to me was the mention of 2 more clinical trials beginning by the end of the year. Which will total 6 for Anatabine all together so far.
I'd assume MS would be one of them, maybe TBI, Parkinson's, maybe high cholesterol, maybe IBD, so many to pick from its hard to tell which ones it will be. Maybe even the unveiling of the Anatabloc inhaler and an asthma trial. Whichever the two are I can't wait for them to be announced. So many catalysts building up for Star. At this point its crazy to see STSI is still under $2. Not for much longer.
GLTAL